Torsemide in the Management of Pulmonary Edema.
J Assoc Physicians India
; 72(9S): 38-39, 2024 Sep.
Article
en En
| MEDLINE
| ID: mdl-39291573
ABSTRACT
Pulmonary edema, either cardiogenic or noncardiogenic, is caused by fluid accumulation in the alveolar spaces. Cardiogenic pulmonary edema (CPE), one of the causes of congestive heart failure (CHF), is treated with loop diuretics. Torsemide and furosemide were found to be useful in the treatment of CHF-associated pulmonary edema due to their ability to lower pulmonary capillary pressure and left ventricular end-diastolic pressure, respectively. Pharmacological features of torsemide, such as greater bioavailability, higher absorption rate, and efficacy, make it a better alternative for treating pulmonary edema than the regularly used loop diuretic, furosemide. Torsemide administered intravenously was found to be both efficacious and well tolerated in CPE. However, more research is needed to determine its usefulness in non-CPE.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Edema Pulmonar
/
Inhibidores del Simportador de Cloruro Sódico y Cloruro Potásico
/
Torasemida
/
Insuficiencia Cardíaca
Límite:
Humans
Idioma:
En
Revista:
J Assoc Physicians India
Año:
2024
Tipo del documento:
Article
Pais de publicación:
India